Biggest Losers (CHTP,ILI,CNXT,HERO,NMR)

Chelsea Therapeutics International Ltd. (NASDAQ: CHTP) plummeted 66% to $2.35 on huge volume of 26.84 million shares after its neurological disorder drug didn't meet the primary endpoint of a late-stage study. The biopharmaceutical development company said that in the first of two Phase III studies, the drug, Droxidopa, did not demonstrate a statistically significant improvement relative to placebo, as measured by the mean score of dizziness or light-headedness of the Orthostatic Hypotension Symptom Assessment.

Interleukin Genetics, Inc (AMEX: ILI) after yesterday’s rally of over 270% today the stock corrected 21% to $1.38 on unusual volume of 1.20 million shares

Conexant Systems, Inc. (NASDAQ: CNXT) decreased $0.55 or 16% to $2.94 on huge volume of 2.65 million shares after it announced the pricing of an underwritten public offering of 7 million shares of its common stock at a price to the public of $2.85 per share.

Nomura Holdings, Inc. (ADR) (NYSE: NMR)  fell 14% to $6.58 on very unusual volume of 1.22 million shares after it said on Thursday it would raise JPY 257.2 billion ( USD 2.8 billion ) through the new issuance of 400 million common shares.

Hercules Offshore, Inc. (NASDAQ: HERO)plunged 13% to $5.47 on huge volume of 3.91 million shares after The operator of drilling rigs and liftboats forecast third-quarter sales that missed analysts’ estimates and said it plans to offer as many as 17.5 million shares to repay debt.